HFA-ICOS Baseline Cardio-Oncology Risk Assessment for Anthracycline Chemotherapy

Código: 10642 · hfa_icos_baseline_cardio_oncology_risk_assessment_anthracycline_chemotherapy

Stratifies cardiotoxicity risk in cancer patients scheduled to receive anthracycline-based chemotherapy.